City

Seoul (1)

Condition

Recurrent Hepatocellular Cancer (2)

Chronic Liver Disease and Cirrhosis (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

n/a (2)

Sponsor

Henan Cancer Hospital (1)

Seoul National University Hospital (1)

Collaborator

RF medical (1)

Intervention

lenvatinib (1)

radiofrequency ablation (1)

radiofrequency ablation using combined bipolar and monopolar energy deliver with triple cooled-wet electrodes (1)

toripalimab (1)

Study Documents

Intervention Type

device (1)

drug (1)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

recurrent hepatocellular cancer

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Recurrent Hepatocellular Cancer, Chronic Liver Disease and Cirrhosis Trial in Seoul (Radiofrequency ablation using combined

Recruiting

Recurrent Hepatocellular Cancer
Chronic Liver Disease and Cirrhosis

Radiofrequency ablation using combined bipolar and monopolar energy deliver with Triple Cooled-Wet electrodes

Seoul, Korea, Republic of

Seoul National University Hospital

Oct 10, 2022

Recurrent Hepatocellular Cancer Trial (toripalimab, Lenvatinib, Radiofrequency ablation)

Not yet recruiting

Recurrent Hepatocellular Cancer

toripalimab
+2 more

(no location specified)

Jan 12, 2022